PLAU and diabetes mellitus: Further experiments show that increasing Serpine1 up-regrates the expression of Plau, Plaur and MMP-3 in the cornea of DM mice (60), which indicates that targeting uPA proteolytic pathway is a promising option for regulating MMP-3 in treating diabetic keratopathy.